Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension (vol 121, pg 2348, 2014)

被引：0
|
作者：
Aung, T.
Laganovska, G.
Hernandez Paredes, T. J.
机构：
来源：
OPHTHALMOLOGY | 2015年 / 122卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：2149 / 2149
页数：1
相关论文
共 50 条
  • [41] The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension
    Manni, Gianluca
    Denis, Phillipe
    Chew, Paul
    Sharpe, Elisabeth D.
    Orengo-Nania, Silvia
    Coote, Michael A.
    Laganovska, Guna
    Volksone, Lasma
    Zeyen, Thierry
    Filatori, Isabella
    James, John
    Aung, Tin
    JOURNAL OF GLAUCOMA, 2009, 18 (04) : 293 - 300
  • [42] The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Akcay, Betul Ilkay Sezgin
    Guney, Esra
    Bozkurt, Kansu Tahir
    Unlu, Cihan
    Akcali, Gulunay
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (10) : 882 - 886
  • [43] Preliminary results following the use of a fixed combination of timolol-brimonidine in patients with ocular hypertension and primary open-angle glaucoma
    Papaconstantinou, Dimitris
    Georgalas, Ilias
    Kourtis, Nikolaos
    Pitsas, Christos
    Karmiris, Efthimios
    Koutsandrea, Chrysanthi
    Ladas, Ioannis
    Georgopoulos, Gerasimos
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 227 - 230
  • [44] Effect of Prostaglandin Analog Type in a Study Comparing the Additive Effect of Brinzolamide 1%/Brimonidine 0.2% in Patients with Open-Angle Glaucoma or Ocular Hypertension Treated with a Prostaglandin Analog
    Myers, Jonathan S.
    Dubiner, Harvey
    Budenz, Donald L.
    Hubatsch, Douglas
    Fechtner, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [45] Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
    Beckers, Henny J. M.
    Schouten, Jan S. A. G.
    Webers, Carroll A. B.
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 593 - 599
  • [46] Twice-daily 0.2% brimonidine 0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension -: A 12-month randomized trial
    Sherwood, Mark B.
    Craven, E. Randy
    Chou, Connie
    DuBiner, Harvey B.
    Batoosingh, Amy L.
    Schiffman, Rhett M.
    Whitcup, Scott M.
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (09) : 1230 - 1238
  • [47] Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma
    Joshi, Sachin R.
    Akat, Pramod B.
    Ramanand, Jaiprakash B.
    Ramanand, Sunita J.
    Karande, Vitthal B.
    Jain, Suyog S.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (12) : 765 - 767
  • [48] Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension
    Orzalesi, N
    Rossetti, I
    Bottoli, A
    Invernizzi, T
    Fumagalli, E
    Fogagnolo, P
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 : 55 - 55
  • [49] Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
    Nakajima, Masayuki
    Iwasaki, Naoki
    Adachi, Masaki
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 149 - 156
  • [50] Demographic Subgroup Analysis in a Study Comparing the Additive Effect of Brinzolamide 1%/Brimonidine 0.2% in Patients with Open-Angle Glaucoma or Ocular Hypertension Treated with TRAVATAN Z® (NCT01937299)
    Katz, Gregory
    Mcmenemy, Matthew
    Hubatsch, Douglas
    Realini, Tony
    Feldman, Robert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345